Orphenadrine Citrate

Product manufactured by Direct Rx

Application Nr Approved Date Route Status External Links
ANDA040284 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Orphenadrine Citrate Extended-Release Tablets Are Indicated As An Adjunct To Rest, Physical Therapy, And Other Measures For The Relief Of Discomfort Associated With Acute Painful Musculoskeletal Conditions.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Orphenadrine Citrate ORPHENADRINE CITRATE ZINC155269

Comments